NEW YORK (GenomeWeb) – Symbiodx, a molecular reference laboratory, is partnering with Cure Forward to provide patients with improved access to their genomic data and greater exposure to relevant clinical trials.

Symbiodx performs more than 300,000 biopsies annually using a custom next-generation sequencing assay. Its results help pathologists and oncologists select appropriate treatments and improve outcomes for patients with solid and hematologic cancers.